Congratulations to Dr. Mi-Hyeon Jang on her promotion to Full Professor. Dr. Jang, a BHI core member and faculty member in the Department of Neurosurgery at Robert Wood Johnson Medical School, has had a longstanding interest in the field of regenerative medicine. The focus of research in Dr. Jang’s laboratory is to understand the underlying neurobiological mechanisms that promote regenerative processes of adult neurogenesis, oligodendrogenesis, and myelination. We hope to discover novel regenerative strategies for improving learning and memory function in brain aging, as well as neurological and neurodegenerative disorders. Building on my earlier work in brain aging, Dr. Jang’s laboratory pursues a new direction focused on chemotherapy-induced cognitive impairment (also known as chemobrain) which resembles the brain aging process. Given that multiple molecular pathways contribute to the pathogenesis of chemobrain, we aim to uncover the molecular contributors driving chemobrain to direct development of rationally designed synergistic “disease-modifying therapeutic strategies” to ameliorate chemobrain, thus ultimately improving quality of life for cancer survivors. Dr. Jang is an active full member of the Cancer Pharmacology Program at Cancer Institute of New Jersey (CINJ).
Learn more: https://molbiosci.rutgers.edu/faculty-research/faculty/faculty-detail/984-jang-mi-hyeon
